Literature DB >> 10200012

Increased production of IFN-gamma and cysteinyl leukotrienes in virus-induced wheezing.

S M van Schaik1, D A Tristram, I S Nagpal, K M Hintz, R C Welliver, R C Welliver.   

Abstract

BACKGROUND: An imbalance of production of T-helper lymphocyte cytokines, favoring overproduction of IL-4, is believed to be important in the pathogenesis of allergic asthma. However, less is known about the cytokine response in virus-induced wheezing, which is a major cause of morbidity in asthma.
OBJECTIVE: We undertook this study to determine the magnitude of IFN-gamma, IL-4 and IL-10, and leukotriene (LT) responses in infants and children with virus-induced wheezing.
METHODS: We measured the concentrations of IFN-gamma, IL-4 and IL-10, and cysteinyl LTs in respiratory secretions of 82 infants and young children during acute episodes of virus-induced wheezing. Control subjects were 47 infants and children with uncomplicated upper respiratory infections and 18 normal healthy infants.
RESULTS: Ratios of IFN-gamma to IL-4 were higher (due to increased quantities of IFN-gamma) in subjects with wheezing than in those with upper respiratory infection alone (P =. 003). Quantities of LTs were also increased in wheezing subjects in comparison with those with upper respiratory infections (P =.009). There was a significant correlation between measured concentrations of IFN-gamma and LTs (correlation coefficient =.451, P =.007). Quantities of IL-4 were slightly suppressed in the wheezing groups.
CONCLUSIONS: An imbalance favoring overproduction of IFN-gamma appears to be associated temporarily with virus-induced wheezing. A possible mechanism is the enhanced release of LTs from eosinophils or mast cells after sensitization by IFN-gamma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10200012     DOI: 10.1016/s0091-6749(99)70235-6

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  39 in total

1.  Breastfeeding is associated with the production of type I interferon in infants infected with influenza virus.

Authors:  Guillermina A Melendi; Silvina Coviello; Niranjan Bhat; Johanna Zea-Hernandez; Fausto M Ferolla; Fernando P Polack
Journal:  Acta Paediatr       Date:  2010-10       Impact factor: 2.299

2.  Predominant type-2 response in infants with respiratory syncytial virus (RSV) infection demonstrated by cytokine flow cytometry.

Authors:  K Bendelja; A Gagro; A Bace; R Lokar-Kolbas; V Krsulovic-Hresic; V Drazenovic; G Mlinaric-Galinovic; S Rabatic
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

3.  Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation.

Authors:  Chang Keun Kim; Zak Callaway; Young Yull Koh; Soo-Hee Kim; Takao Fujisawa
Journal:  Lung       Date:  2011-12-13       Impact factor: 2.584

Review 4.  [Childhood asthma and viral infection: interactions and therapeutic possibilities].

Authors:  M Boquete; F Carballada
Journal:  Allergol Immunopathol (Madr)       Date:  2001 May-Jun       Impact factor: 1.667

5.  Mucosal inoculation with an attenuated mouse pneumovirus strain protects against virulent challenge in wild type and interferon-gamma receptor deficient mice.

Authors:  John A Ellis; Brittany V Martin; Cheryl Waldner; Kimberly D Dyer; Joseph B Domachowske; Helene F Rosenberg
Journal:  Vaccine       Date:  2006-10-12       Impact factor: 3.641

6.  Montelukast during primary infection prevents airway hyperresponsiveness and inflammation after reinfection with respiratory syncytial virus.

Authors:  Junyan Han; Yi Jia; Katsuyuki Takeda; Yoshiki Shiraishi; Masakazu Okamoto; Azzeddine Dakhama; Erwin W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  2010-05-04       Impact factor: 21.405

7.  Cooperative activation of CCL5 expression by TLR3 and tumor necrosis factor-alpha or interferon-gamma through nuclear factor-kappaB or STAT-1 in airway epithelial cells.

Authors:  Tetsuya Homma; Satoshi Matsukura; Takashi Hirose; Tsukasa Ohnishi; Teruaki Kimura; Masatsugu Kurokawa; Koushi Ieki; Miho Odaka; Shintaro Suzuki; Shin Watanabe; Masayuki Sato; Mio Kawaguchi; Robert P Schleimer; Mitsuru Adachi
Journal:  Int Arch Allergy Immunol       Date:  2010-06-04       Impact factor: 2.749

Review 8.  The immune response to respiratory syncytial virus infection: friend or foe?

Authors:  Robert C Welliver
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

9.  Viral respiratory infection and the link to asthma.

Authors:  James E Gern
Journal:  Pediatr Infect Dis J       Date:  2008-10       Impact factor: 2.129

Review 10.  Asthma: clinical expression and molecular mechanisms.

Authors:  Robert F Lemanske; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2010-02       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.